Trademark: 'Targeted Oncology' 
ImClone LLC
European Community Trademark, no. 001920198, Figurative mark

 

On 24. 10. 2000 the community trademark application no. 001920198 was filed for Targeted Oncology (Figurative mark) by ImClone LLC before the OAMI.The goods and services in respect of which registration of the trademark was sought are in class 5. The current status of the trademark is registered.

Status is 'Registered'
The Community Trade Mark has been registered for the European Union.

Registered22. 3. 2002
Expiry date24. 10. 2020
Nice classes5

 
 

You can follow this trademark. You will receive an email, whenever we detect changes of the trademark filing.
This service is for free. You can unsubsribve whenever you want. More information.

 

Owner

ImClone LLC
180 Varick Street, 6th Floor
10014 New York,
US

 

If you are the trademark owner and the data above are not correct, then please update them soon by clicking on Update address.

If you want to transfer the trademark to another owner, click on Transfer trademark.

You can transfer a trademark partially or completely to another owner. A partial transfer means that you can transfer a trademark in specific classes.

Still questions? Call us : 0049 (0) 89 6666 10 89

Representative

PAGE WHITE & FARRER
Bedford House, John Street
WC1N 2BF London
GB

 

If the data above is not correct, then please choose Update.

 
 

Nice classes

5  Pharmaceutical preparations for treatment of cancer.

 

Vienna classes

 
 

Records history

 
24.10.2020 Expiry
Expiry date of the trademark 001920198 Targeted Oncology
9.12.2016 The current state is Registered
Current state
12.11.2010 Trade mark renewed
D.1 Renewal of a mark
8.6.2009 Published
Representative - Replacement of representative
11.3.2009 Published
Proprietor - Change of name and address
26.11.2007 Published
Representative - Change of name and professional address
9.7.2007 Published
Representative - Change of name and professional address
22.3.2002 Registration
Registration of the trademark 001920198 Targeted Oncology
28.3.2001 Registered
Representative - Change of name and professional address
24.10.2000 Application
Application of the trademark 001920198 Targeted Oncology
 

Further trademarks of the owner

VACCINES ANGIOGENESIS INHIBITORS GROWTH FACTOR BLOCKERS
ERBITUX CETUXIMAB
ERBITUX